Table: Torii Pharmaceutical -2017 parent results
Feb 6 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2017 Dec 31, 2016 Dec 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 64.14 60.21 60.70
(+6.5 pct) (-3.5 pct) (-5.4 pct)
Operating 6.28 3.82 3.50
(+64.5 pct) (-22.4 pct) (-44.3 pct)
Recurring 6.40 4.00 3.60
(+60.1 pct) (-22.1 pct) (-43.8 pct)
Net 4.72 2.84 2.60
(+66.1 pct) (-19.5 pct) (-44.9 pct)
EPS 168.22 yen 100.41 yen 92.70 yen
EPS Diluted 168.22 yen
Ann Div 48.00 yen 48.00 yen 48.00 yen
-Q2 Div 24.00 yen 24.00 yen 24.00 yen
-Q4 Div 24.00 yen 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)